Publicacións en colaboración con investigadores/as de Hospital Ramón y Cajal (29)

2021

  1. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis

    Schizophrenia Research, Vol. 236, pp. 19-28

  2. The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis

    Psychopharmacology, Vol. 238, Núm. 3, pp. 665-676

2020

  1. Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study

    Schizophrenia Research, Vol. 218, pp. 292-294

  2. Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis

    Psychological Medicine, Vol. 50, Núm. 16, pp. 2702-2710

  3. Suicide. The post-COVID era: A time for action

    Revista de Psiquiatria y Salud Mental

2019

  1. Barriers to complete recovery of major depression: cross-sectional, multi-centre study on clinical practice. RECORD study

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 3, pp. 141-150

  2. Patient characteristics driving clinical utility in psychiatric pharmacogenetics: a reanalysis from the AB-GEN multicentric trial

    Journal of Neural Transmission, Vol. 126, Núm. 1, pp. 95-99

  3. Pharmacological treatment of obsessive compulsive disorder in adults: A clinical practice guideline based on the ADAPTE methodology

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 2, pp. 77-91

2018

  1. Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis

    Schizophrenia Research, Vol. 193, pp. 188-196

  2. Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables

    Acta Psychiatrica Scandinavica, Vol. 138, Núm. 2, pp. 145-154

  3. Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?

    Psychological Medicine, Vol. 48, Núm. 13, pp. 2247-2256

2017

  1. Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study

    European Neuropsychopharmacology, Vol. 27, Núm. 4, pp. 350-359

  2. Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: Results of a randomized, double-blind clinical trial

    BMC Psychiatry, Vol. 17, Núm. 1

  3. The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study

    Schizophrenia Research, Vol. 189, pp. 84-90

2016

  1. Antipsychotic switching in schizoaffective disorder: A systematic review

    World Journal of Biological Psychiatry, Vol. 17, Núm. 7, pp. 495-513

  2. Cognitive reserve in bipolar disorder: Relation to cognition, psychosocial functioning and quality of life

    Acta Psychiatrica Scandinavica, Vol. 133, Núm. 5, pp. 386-398

  3. Effects of functional remediation on neurocognitively impaired bipolar patients: Enhancement of verbal memory

    Psychological Medicine, Vol. 46, Núm. 2, pp. 291-301

  4. Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome

    British Journal of Psychiatry, Vol. 208, Núm. 1, pp. 87-93

2014

  1. Antipsychotic switching in bipolar disorders: A systematic review

    International Journal of Neuropsychopharmacology, Vol. 17, Núm. 3, pp. 497-507

  2. Consenso español de salud física del paciente con depresión

    Revista de Psiquiatria y Salud Mental, Vol. 7, Núm. 4, pp. 195-207